[OPG(osteoprotegerin)/OCIF(osteoclastogenesis inhibitory factor)].
Inoue
Daisuke
D
Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine.
D000818:Animals; D001851:Bone Diseases, Metabolic / Q000209:etiology; D001862:Bone Resorption / Q000235:genetics; D001842:Bone and Bones / Q000378:metabolism; D002454:Cell Differentiation / Q000235:genetics; D018507:Gene Expression Regulation, Developmental; D006023:Glycoproteins / Q000235:genetics / Q000502:physiology; D006801:Humans; D009154:Mutation; D010010:Osteoclasts / Q000166:cytology / Q000502:physiology; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics / Q000502:physiology; D018124:Receptors, Tumor Necrosis Factor
D006023:Glycoproteins; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506030:TNFRSF11B protein, human